Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 7 studies | 46% ± 15% | |
epithelial cell | 4 studies | 31% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 77% | 8210.41 | 746 / 966 | 84% | 94.87 | 442 / 527 |
pancreas | 87% | 104.73 | 286 / 328 | 20% | 7.53 | 36 / 178 |
stomach | 15% | 7.21 | 55 / 359 | 72% | 74.36 | 207 / 286 |
spleen | 79% | 20.81 | 190 / 241 | 0% | 0 | 0 / 0 |
bladder | 29% | 5.57 | 6 / 21 | 26% | 22.75 | 133 / 504 |
lung | 38% | 6.20 | 220 / 578 | 10% | 2.85 | 112 / 1155 |
brain | 40% | 8.25 | 1059 / 2642 | 4% | 0.12 | 27 / 705 |
liver | 16% | 1.82 | 36 / 226 | 26% | 9.34 | 105 / 406 |
esophagus | 12% | 9.33 | 169 / 1445 | 27% | 18.61 | 49 / 183 |
prostate | 26% | 4.00 | 63 / 245 | 1% | 0.03 | 5 / 502 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.13 | 7 / 29 |
breast | 19% | 21.16 | 86 / 459 | 1% | 0.03 | 6 / 1118 |
adipose | 18% | 3.39 | 216 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 17% | 1.96 | 44 / 258 | 0% | 0 | 0 / 230 |
skin | 12% | 2.04 | 216 / 1809 | 0% | 0.11 | 2 / 472 |
uterus | 9% | 3.26 | 15 / 170 | 3% | 1.10 | 14 / 459 |
ovary | 11% | 2.44 | 19 / 180 | 0% | 0.37 | 2 / 430 |
thymus | 9% | 1.18 | 59 / 653 | 0% | 0.02 | 3 / 605 |
blood vessel | 7% | 1.02 | 95 / 1335 | 0% | 0 | 0 / 0 |
muscle | 6% | 0.72 | 50 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 0.67 | 57 / 929 | 0% | 0 | 0 / 0 |
kidney | 4% | 0.48 | 4 / 89 | 1% | 0.02 | 5 / 901 |
heart | 4% | 0.47 | 33 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0140448 | Biological process | signaling receptor ligand precursor processing |
GO_0038004 | Biological process | epidermal growth factor receptor ligand maturation |
GO_0005615 | Cellular component | extracellular space |
GO_0017090 | Cellular component | meprin A complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0070573 | Molecular function | metallodipeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008237 | Molecular function | metallopeptidase activity |
Gene name | MEP1A |
Protein name | Metalloendopeptidase (EC 3.4.24.-) Meprin A subunit alpha (EC 3.4.24.18) (Endopeptidase-2) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit alpha) (PABA peptide hydrolase) (PPH alpha) Meprin A subunit (EC 3.4.24.-) (Endopeptidase-2) |
Synonyms | |
Description | |
Accessions | ENST00000680229.1 ENST00000230588.9 Q16819 B7ZL91 A0A7P0Z478 ENST00000611727.2 |